Several reports have demonstrated a marked increase in the IL-17+CD4+T-cell population (Th17) derived from AD patients compared with healthy controls, and the highest percentage of IL-17-producing CD4+T cells was found in severe AD, suggesting Th17 is the major cellular source of IL-17 in AD14, 15. This evidence concerns the gene IL17A and Alzheimer disease.